Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Bellevue Life Sciences Acquisition

BLAC

3.0100.00% ( 0.000 )

Suspended: Aug 5, 09:20:00 (EDT)

OverviewOverview OptionsOptions NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

Bellevue shareholders back board and approve CHF 0.15 dividend
Tip Ranks·Mar 24 at 12:04 PM
BLAC0.00%
LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories | BBCMF Stock News
StockTitan·Feb 5 at 09:00 AM
IDXX-56.00%BLAC0.00%
REG - Bellevue Healthcare - Net Asset Value(s)
London Stock Exchange·Feb 5 at 03:41 AM
BLAC0.00%